University of California San Francisco
Give to UCSF
UCSF Nobel laureate Elizabeth Blackburn, PhD, and researcher Elissa Epel, PhD, are co-authors with UC Davis scientists of a paper showing that the positive psychological changes that occur during meditation training are associated with greater activity of the enzyme telomerase.
UCSF will hold a groundbreaking ceremony on Tuesday, October 26 for the new UCSF Medical Center at Mission Bay, a world-class hospital complex for children, women and cancer patients.
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
The UCSF Diabetes Center will celebrate a decade of advancing translational research in diabetes on Friday, with a scientific symposium featuring the nation’s leaders in diabetes research and care.
UCSF is co-sponsoring a symposium on September 27 and 28 to provide scientists and physicians with the “nuts and bolts” of translating stem cell science into cell-based products for clinical trials.
Frank McCormick, director of the UCSF Helen Diller Family Comprehensive Cancer Center, is the recipient of the 2010 American Society of Clinical Oncology's Science of Oncology Award and Lecture.
With innovation as the watchword, a biotech spinoff from the UCSF School of Pharmacy announced a $40 million Series A round of investment last week – hailed by an investor as “one of the largest first rounds of financing in some time.”
Researchers have identified how a normal response to infection, one that usually serves to limit the amount of inflammation, actually contributes to disease progression and viral persistence in HIV-infected patients.
A long-held vision came into view Monday as UCSF neuroscientists and clinical researchers shared their ambitious plans to attack debilitating neurological diseases through innovative collaborations.
UCSF Chancellor Sue Desmond-Hellmann recently urged stem cell researchers to focus on the primary goal – making new treatments broadly available to benefit patients.
Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.